ŠĻą”±į>ž’ ’”ž’’’‘’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’ģ„Įq` šæv?bjbjqPqP kn::$7Q’’’’’’¤8888888$\ä:ä:ä:P4;,`;Œ\ļyhų;ų;:2<2<2<f=f=f=nypypypypypypy$W{hæ}T”y86Bf=f=6B6B”y882<2<4©y F F F6BX82<82<ny F6Bny F Fś>tl88Bw2<ģ; €®­™ŠĢä:ŽBpŖu*Zyæy0ļyŌunžB¶TBw8Bwf=dŹ>ž FČ?Ģ”@¢f=f=f=”y”y“EXf=f=f=ļy6B6B6B6B\\\$€"d\\\€"\\\888888’’’’ 10-144 MAINE DEPARTMENT OF HEALTH AND HUMAN SERVICES MAINE CENTER FOR DISEASE CONTROL & PREVENTION DIVISION OF FAMILY HEALTH MATERNAL, FETAL & INFANT MORTALITY REVIEW PANEL Chapter 700: RULES AND REGULATIONS RELATING TO THE MATERNAL, FETAL AND INFANT MORTALITY REVIEW PANEL SUMMARY: These rules establish the responsibilities of the fb88 Maternal, Fetal and Infant Mortality Review Panel in regard to collection of data, panel membership, conducting family interviews, confidentiality, the nature of contact between the fb88 Maternal, Fetal and Infant Mortality Review Panel with families and access to medical records, and the conduct of reviews of maternal, fetal and infant deaths. PURPOSE AND STATUTORY AUTHORITY These rules implement the Department’s duties and responsibilities in the establishment of a maternal, fetal and infant mortality review panel as enacted by P.L. 2005, c. 467 and P.L. 2009, c. 531, codified at 22 M.R.S.A. §261. Definitions As used in this section, unless the context otherwise indicates, the following terms have the following meanings. “Authorized Representative” means parent, guardian or guardian ad litem, or other person authorized by the parent or guardian to act as a representative. "fb88 CDC" means the fb88 Center for Disease Control and Prevention, Department of Health and Human Services. "Deceased person" means a woman who died during pregnancy or within 42 days of giving birth or a child who died within 1 year of birth. "Director" means the director of the fb88 Center for Disease Control and Prevention, Department of Health and Human Services. “Family” means a woman who has experienced a fetal death, or the parent or parents or other authorized representative of a deceased person. "Panel" means the maternal, fetal and infant death review panel established under this section. "Panel Coordinator" means an employee of the fb88 Center for Disease Control and Prevention who is appointed by the Director, or a person(s) designated by the Panel The “Panel Coordinator” must be a licensed physician or registered nurse or other health care professional licensed or registered in this State. The Panel Coordinator provides administrative oversight and project management and support for the fb88 Maternal and Infant Mortality Review Panel. “Home Interviewer” means a person under the direction and at the discretion of the Panel Coordinator who shall meet the requirements for Panel Coordinator and have professional training or experience in bereavement services. “Hospital” means any facility licensed under the provisions of Title 22 of the fb88 Revised Statutes, which provides health care services. “Specialty Provider” means those persons licensed pursuant to Title 32 of the fb88 Revised Statutes who have additional certification by or eligibility for one of the disciplines of the American boards of certification and who are registered and certified by the appropriate specialty boards. The “Medical Director” means an employee of the fb88 Center for Disease Control and Prevention who is a licensed physician within the State of fb88 who shall oversee Panel operations and Panel appointments. “State Health Officer” means the Director of the fb88 Center for Disease Control and Prevention. RESPONSIBILITies OF MEDICAL director The Medical Director shall recommend the size of the Panel; and shall recommend the Panel Coordinator, all members of the Panel, and replacements to the Director of the fb88 CDC. The Medical Director shall provide oversight and guidance in all aspects of Panel development, implementation and operation. The Medical Director shall appoint the Home Interviewer, who must meet the qualifications of the Panel Coordinator and shall have professional experience or training in bereavement services. The Medical Director shall have authority to seek funds and authorize disbursements for Panel functions. The Medical Director shall have authority to recommend removal of Panel members for failure to discharge their duties. RESPONSIBILITies OF PANEL COORDINATOR The Panel Coordinator has the following duties and powers pursuant to 22 M.R.S.A. §261(4): The Panel Coordinator may appoint suitable persons as Designees to perform or assist with the duties of the Panel Coordinator. Any Designee appointed by the Panel Coordinator shall possess sufficient experience and/or training to conduct the activity and shall operate at all times under the direct supervision of the Panel Coordinator. The Panel Coordinator or designee(s) shall maintain a central registry of statewide organizations dedicated to improving the health of mothers and infants by preventing birth defects, premature births, and maternal and infant mortality The Panel Coordinator or designee(s) shall review the deaths of all women, currently residents of fb88, who die during pregnancy or within 42 days of giving birth. Should the Panel Coordinator determine that medical record review is necessary for selected cases, the Panel Coordinator shall first obtain written consent in accordance with state and federal law for that review from the family, no sooner than four months after the date of death. The Panel Coordinator or designee(s) shall review the majority of cases in which a fetal death occurs after 28 weeks of gestation when not the result of an abortion and in which the mother is currently a resident of fb88. Should the Panel Coordinator determine that medical record review is necessary for selected cases, the Panel Coordinator shall first obtain written consent in accordance with state and federal law for that review from the family, no sooner than four months after the date of death. The Panel Coordinator or designee(s) shall review a majority of infant deaths and determine the selection of cases based on the need to review particular causes of deaths or to obtain a representative sample of all infant deaths. Should the Panel Coordinator determine that medical record review is necessary for selected cases, the Panel Coordinator shall first obtain written consent in accordance with state and federal law for that review from the family, no sooner than four months after the date of death. The Panel Coordinator or designee(s) shall prepare a summary of relevant information regarding the case, removing any identifying information prior to case presentation, and shall not release, furnish, disclose, publish, or otherwise disseminate any identifying information. The Panel Coordinator or designee(s) may conduct voluntary interviews with the of a deceased mother, fetus and/or infant, subject to the requirements of 22 M.R.S.A. §261(4)(D). The Panel Coordinator or designee(s) shall inform any interested parties of the purpose and function of the Panel. PANEL MEMBERSHIP The fb88 CDC Director, upon recommendations from the Medical Director, shall appoint Panel members, who shall serve at his or her pleasure. The Panel members shall consist of health and social service providers, public health officials, law enforcement officers, and other persons with professional expertise in maternal and infant health and mortality. Responsibilities of Panel Members All members of the Panel shall sign a confidentiality agreement regarding case review conduct and assurances of confidentiality when working with case specific data. All members of the Panel shall discharge in a timely manner their following duties and powers: The Panel shall conduct comprehensive multidisciplinary reviews of the case summary presented by the Panel Coordinator. The Panel shall present an annual report to the Department of Health and Human Services and to the joint standing committee of the Legislature having jurisdiction over health and human services matters. The Department may publish the annual report, or excerpts thereof, at its discretion. The report must identify factors contributing to maternal, fetal and infant death in the State, determine the strengths and weaknesses of the current maternal and infant health care delivery system and make recommendations to the Department to decrease the rate of maternal, fetal and infant deaths. The Panel shall offer a copy of the annual report to the person or persons that granted permission to the Panel Coordinator for a voluntary interview or medical record review. The Panel shall share the results of its data reviews and recommendations with the fb88 Child Death and Serious Injury Review Panel established pursuant to 22 M.R.S.A. §4004(1)(E). The Panel may request and review data from the Child Death and Serious Injury Review Panel. Responsibilities of the Home interviewer The Home Interviewer shall collect data that is limited for the purposes of the Panel in summary or abstract form without family names or patient identifiers. The Home Interview shall only take place as long as a valid and written signed consent remains in effect. The consent shall remain in effect unless revoked. The Home Interviewer may make a referral for bereavement counseling with family consent. Responsibilities of Those Providing Services Any healthcare facility or healthcare provider shall provide access to medical records and other information pursuant to State and Federal Laws. A health care practitioner, hospital or healthcare facility, or the employee or agent of that person or entity is not subject to civil or criminal liability arising from the disclosure or furnishing of records or information to the Panel pursuant to 22 M.R.S.A. §261(8). Contact with Families The Panel Coordinator shall not contact families prior to 4 months after the date of the death of the mother, fetus or infant. Initial family contact shall occur through a letter from the State Health Officer on the letterhead of the fb88 Center for Disease Control and Prevention and shall include the following information: An invitation for the family to participate in a home interview and/or medical record review through a voluntary process. The data gathered will be used to determine and understand the significant social, economic, cultural, safety, and health care delivery system factors that are associated with fetal, infant and maternal mortality. The information obtained is confidential, and the name of the deceased person and his or her family or other identifying information cannot be released. A family may decline participation in the home interview, medical record review, or both. Information on bereavement services shall be offered regardless of status of participation in the interview and/or review process. The initial family contact shall also include an invitation to participate in a review of the death of the deceased person from a statewide organization dedicated to improving the health of babies by preventing birth defects, premature birth and infant mortality. Upon family request, referrals shall be made to the Department of Health and Human Services, Public Health Nursing, to provide information on available services. No family shall be required to accept any services offered. In the event of documented family objection to participation or indication of unwillingness to participate, the Panel Coordinator shall not collect or gather any confidential medical information relating to death of the infant and/or mother. In the event the family wishes to revoke the consent, the Panel shall not pursue any further review of the case. Confidentiality of all individually identifiable health Information All data collected or developed by the Panel Coordinator, containing either direct or indirect individually identifiable information, shall be confidential and privileged and will not be considered a public record. Confidential medical information submitted to or developed by the Panel Coordinator shall only be available to the Panel Coordinator for the purposes of analysis prior to de-identification of such information to the Panel. In the event a proposed research plan involves contacting family members, written consent of the family of any deceased fetus, infant or mother shall be required for use or release of any information by the Panel Coordinator. All data will be maintained in a manner consistent with 22 M.R.S.A. §42(5) and §261(7). Confidentiality provisions which govern the Panel will be reviewed periodically to ensure that public confidence in the ability of the Panel and fb88 CDC to safeguard individually identifiable information will be maintained. LIMITATIONS OF USE OF IDENTIFYING INFORMATION The Panel Coordinator shall ensure that any information collected or developed by the Panel is necessary for the conduct of an appropriate maternal or infant death review. Access to privileged medical information is restricted to the Panel Coordinator or designee(s) and is essential for the conduct of such investigations. Tasks performed by the Panel Coordinator or designee(s) shall include, but not be limited to, the following functions: Medical record reviews. Audits and abstractions. Review of discharge summaries. Compilation of datasets. Analysis of vital statistic data with confidential data elements. Identifying information shall be used only to gain access to medical records and other medical information pertaining to case findings. Identifying information shall be used to the minimum extent possible to accomplish the purposes of the approved Panel activities. PURPOSE FOR USE OF IDENTIFYING INFORMATION The Panel Coordinator or designee(s) may only use individually identifying information for the following purposes: Verification and validation of maternal, fetal and infant death oversight, including accuracy of data and document linkage to avoid duplication of occurrence, through contact with hospitals and other institutions regarding data gathering and management. Full scale epidemiological study of factors contributing to fetal, infant and maternal deaths. STATUTORY AUTHORITY: 22 M.R.S.A. §261 EFFECTIVE DATE: February 6, 2008 – filing 2008-65 AMENDED: December 24, 2011 – filing 2011-468     10-144 Chapter 700 page  PAGE 7 PAGE 3 PAGE 7 % ø ¹ ¼ Ü Ż  ž Į Ā Ć Ī Ļ Š y Š }~ōö5SwxƒßąįóźŽÓĖÓŽĆÓĆÓŗó¬ŽĆӞÓĖӒ†’ÓĆӒӒÓ{m¬_h£;”hżQ 5CJ\aJh£;”h£;”56CJaJhżQ 56CJaJh£;”hżQ CJ]aJh£;”hżQ 6CJaJh£;”hżQ 6CJ]aJh£;”hżQ 5;CJaJhżQ 5CJaJh£;”CJaJh„DéCJaJh£;”hżQ CJaJh£;”hżQ 5CJaJh£;”5CJaJh£;”h£;”5CJaJ#6f‚“µ   ¹ ŗ » ė×ĒĒĒÆŽĒzaĒ ĘŠ p@ ą&dPĘ’gd£;” ĘŠ p@ ą„^„gd£;” ĘŠ p@ ą„ „`ś&dPĘ’^„ `„`śgd£;” ĘŠ p@ ą„ „`ś^„ `„`śgd£;” ĘŠ p@ ągd£;” ĘŠ p@ ą„L’]„L’gd£;” ĘŠ p@ ą„˜ž]„˜žgd£;” $?u?žž» ¼ Ü Ż Į Ā Ć Ļ Š B C Ż ėÖĄĄėėÖ¬¬”s & F ĘxŠ p@ ą„°„ „0ż]„°^„ `„0żgd£;” ĘŠ p@ ą„ „@]„ ^„@gd£;” ĘŠ p@ ą„Š^„Šgd£;” ĘŠ p@ ą„Š*$^„Šgd£;” & F ĘXŠ p@ ągd£;” ĘŠ p@ ą„X^„Xgd£;” Ż Ž N O × Ų WXäåEFķćĆć¢ć¢ć¢ć¢†j$ & F ĘxŠ$ą„ „0ż^„ `„0ża$gd£;” ĘŠ p@ ą„ „ „0ż]„ ^„ `„0żgd£;” & F ĘxŠ p@ ą„°„ „0ż]„°^„ `„0żgd£;”$ & F ĘxŠ$ą„°„ „0ż]„°^„ `„0ża$gd£;” ĘŠ p@ ą„°„ „0ż]„°^„ `„0żgd£;” ķõö‚ƒŖ«|}ßąįćĢć“—“—“—“— ĘŠ p@ ą„Ø„h^„Ø`„hgd£;” & F ĘxŠ p@ ą„ „0ż^„ `„0żgd£;” ĘŠ p@ ą„ „0ż^„ `„0żgd£;”$ Ę Š$ą„ „0ż^„ `„0ża$gd£;”$ & F ĘxŠ$ą„ „0ż^„ `„0ża$gd£;” Ỽ9:łścdŪÜźŚ½„½„„„½„½p ĘŠ p@ ą„^„gd£;” & F Ę(Š p@ ą„ „ „0ż]„ ^„ `„0żgd£;” ĘŠ p@ ą„ „0ż^„ `„0żgd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” ĘŠ p@ ągd£;” & F ĘXŠ p@ ągd£;” `aŗ¼ųłbcŪÜŻ^`įå<>?Į Ā !!""""“"”"•"ģŻĪõíí┆µĆ­Ć{Ć{pĆ­ĆpĆ{Ć­Ć­Ćh]h£;”h—mCJaJh£;”CJaJh£;”h±}ūCJaJh£;”h“'ōCJaJh£;”hżQ 5;CJaJh£;”h£;”5CJ\aJhżQ 5CJ\aJh„DéCJaJh£;”hżQ 5CJ\aJh£;”hżQ CJaJh£;”hżQ B* CJaJph€h£;”hżQ B*CJaJph&h£;”hżQ 5;B*CJ\aJph"ÜŻ_`±²žŸ^_XYY Z m!ėÖ비‘„‘„‘ė‘ė‘„‘ & F ĘŠ p@ ągd£;” ĘŠ p@ ą„Š^„Šgd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” & F ĘXŠ p@ ągd£;” ĘŠ p@ ą„^„gd£;”m!n!" "“"•"¦"§"4#5# $ $ $/$ė×Ć×ė®ė‘y‘ėė® ĘŠ p@ ą„ „0ż^„ `„0żgd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” & F ĘXŠ p@ ągd£;” ĘŠ p@ ą„ ^„ gd£;” & F ĘŠ p@ ągd£;” ĘŠ p@ ą„^„gd£;” •"§"3#4# $ $ $ $.$/$0$z&{&V)W)d)e)Į)Ā)Ć)ģ)„+…+†+³+D,E,C-K-U-V-W-l-ģ-ķ-µ.¶.0/1/ż0ž0‰2Š2\4]4Ļ4óčąčó×˽óÆčąč§čąčœŽ½č†{½čąč§čs{½čąčąčąčąčąčąčhżQ CJaJh£;”h£;”CJaJhœF²CJaJh£;”h£;”5CJ\aJhżQ 5CJ\aJhj6CJaJh£;”hżQ 5CJ\aJh£;”hżQ 5;CJaJh£;”h£;”5CJaJhżQ 5CJaJh„DéCJaJh£;”hżQ CJaJh£;”hżQ 5CJaJ-/$0$Ö$×$6%7%Æ%°%ż'ž'®(Æ(Į)ėĪŗĪ뢊¢v¢v¢ ĘŠ p@ ą„ ]„ gd£;” ĘŠ p@ ą„ „ ]„ ^„ gd£;” & F ĘŠ p@ ą„ ]„ gd£;” ĘŠ p@ ą„^„gd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” ĘŠ p@ ą„Š^„Šgd£;” Į)Ā)Ć)ģ)ķ)Œ***+++„+…+†+³+“+ėėÖĀ”…”Ā”ĀĀÖq ĘŠ p@ ą„Š^„Šgd£;” ĘŠ p@ ą„ „ „0ż]„ ^„ `„0żgd£;” & F Ę(Š p@ ą„ „ „0ż]„ ^„ `„0żgd£;” ĘŠ p@ ą„ ]„ gd£;” & F ĘXŠ p@ ągd£;” ĘŠ p@ ą„(^„(gd£;” “+E,F,U-V-W-m-n-ķ-ī-¶.·.1/2/0āŹāŗŗ„ŗāŹāŗ‘}‘ ĘŠ p@ ą„ ^„ gd£;” & F ĘŠ p@ ągd£;” & F ĘXŠ p@ ągd£;” ĘŠ p@ ągd£;” ĘŠ p@ ą„ „0ż^„ `„0żgd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;”0 0¢0£0ż0ž01‚1Š2‹2-3.3j3k3]4ė×ė×ė×ėŗ¢ŗ’}’ŗ & F Ę(Š p@ ągd£;” ĘŠ p@ ągd£;” ĘŠ p@ ą„ „0ż^„ `„0żgd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” & F ĘŠ p@ ągd£;” ĘŠ p@ ą„ ^„ gd£;”]4^4Ļ4Š4Ń455ķ5ī5Ķ6Ī6°7±7 8 8ģ8ķ8ēŹŗŗŒŹēŹēŹēŹēʌ ĘĄ!Š p@ ągd£;” & F ĘXŠ p@ ą„Š„0ż^„Š`„0żgd£;” ĘŠ p@ ągd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” ĘŠ p@ ą„ „0ż^„ `„0żgd£;”Ļ4Š4Ń45Ķ6Ī6(7.787E7ģ7ō7õ7ö7ģ8ķ8ī89a:b:•<–<—<Ā<—>"?#?$?%?ųķßŌĘԻ԰ԨԠԘķŠŌ ŌqŠŌ`ŌTLjh[“Uh£;”hĒn=5CJaJ h£;”h•%zCJOJQJ^JaJh£;”h£;”5CJ\aJhżQ 5CJ\aJh£;”hżQ 5CJ\aJhżQ CJaJh„DéCJaJhj6CJaJh£;”h«CJaJh£;”hœF²CJaJh£;”hżQ 6CJ]aJh£;”hżQ CJaJh£;”hżQ 5;CJaJh£;”h£;”CJaJh—mCJaJķ8ī899É9Ź9Ł:Ś:ņ:ó: ; ;,;īŁÅؐØÅ|h|h| ĘŠ p@ ą„ ^„ gd£;” & F ĘŠ p@ ągd£;” ĘŠ p@ ą„ „0ż^„ `„0żgd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” ĘŠ p@ ą„^„gd£;” & F ĘXŠ p@ ągd£;” ĘĄ!Š p@ ągd£;” ,;-;F;G;‰;Š;<<•<–<—<Ā<ė×ė×ƦަĆĆy & F ĘXŠ p@ ągd£;” ĘŠ p@ ą„ „0ż^„ `„0żgd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” ĘŠ p@ ą„^„gd£;” & F ĘŠ p@ ągd£;” ĘŠ p@ ą„ ^„ gd£;” Ā<Ć<6=7=5>6>•>–>—>˜>­>ėĪŗ¦ŗ¦‰u]] ĘŠ p@ ą„p„÷^„p`„÷gd£;” ĘŠ p@ ą„^„gdC  ĘŠ p@ ą„&dPĘ’^„gdC  & F ĘŠ p@ ągd£;” ĘŠ p@ ą„Š^„Šgd£;” & F Ę(Š p@ ą„ „0ż^„ `„0żgd£;” ĘŠ p@ ą„X^„Xgd£;” ­>æ>Ą>Š>ō>ż>"?#?$?&?'?)?*?,?-?/?0?W?ēēē×ēēdz±±±±±±±±$ Ęą&dPĘ’a$gdżQ  ĘŠ p@ ą„^„gd£;” ĘŠ p@ ągd£;” ĘŠ p@ ągdC  ĘŠ p@ ą„p„÷^„p`„÷gd£;”%?'?(?*?+?-?.?0?L?M?S?T?U?V?W?X?Z?[?a?b?c?d?e?g?h?n?o?p?q?r?t?u?v?üōüōüōüģŽŌŽÅŽģŗ¶¬¦¬›¬¦¶¬¦¬›¬¦¶üh£;”hĒn=5CJaJh vx0JmHnHu h vx0Jjh vx0JUh vxhš~”h vxCJ aJ h vx0JCJaJmHnHuh vx0JCJaJjh vx0JCJUaJh vxCJaJjh[“Uh[“ W?X?Y?Z?e?f?g?r?s?t?u?v?÷õóźčóźčóóŌ ĘŠ p@ ą„^„gd£;”„ü’„&`#$$a$gdżQ 5 01h:p£;”°Š/ °ą=!° "° # $ %°°Š°Š Š21h:pDķ°Š/ °ą=!° "° # $ %°°Š°Š Š†œ@@ń’@ NormalCJ_HaJmH sH tH DA@ņ’”D Default Paragraph FontVi@ó’³V  Table Normal :V ö4Ö4Ö laö (k@ō’Į(No List >@ņ>  Footnote TextCJaJ@&ņ’@ Footnote ReferenceH*l$@l Envelope Address!„@ „ü’„ō’„š&€+D¼/„“^„@ ;OJQJ^JHC@"H Body Text Indent „h^„hCJ4 @24 Footer  ĘąĄ!.)@¢A. Page Number4B@R4 Body Text5\HR@bH Body Text Indent 2 „Š`„Š4@r4 Header  ĘąĄ!HS@‚H Body Text Indent 3 „Š^„Š^T@’^ Block Text/$ ĘŠ p@ Š$„ „]„ ^„a$H™¢H  Balloon TextCJOJQJ^JaJDZ`²D •%z Plain TextCJOJQJ^JaJķv7 n ’’’’ 7n ’’’’6f‚“µ¹ŗ»¼ÜŻĮĀĆĻŠBCŻŽNO×ŲWXäåEFķ  õ ö ‚ ƒ Ŗ « | } ß ą į   » ¼ 9:łścdŪÜŻ_`±²žŸ^_XYYZmn “•¦§45   /0Ö×67ưżž® Æ Į!Ā!Ć!ģ!ķ!Œ""*#+#„#…#†#³#“#E$F$U%V%W%m%n%ķ%ī%¶&·&1'2'( (¢(£(ż(ž()‚)Š*‹*-+.+j+k+],^,Ļ,Š,Ń,--ķ-ī-Ķ.Ī.°/±/ 0 0ģ0ķ0ī011É1Ź1Ł2Ś2ņ2ó2 3 3,3-3F3G3‰3Š344•4–4—4Ā4Ć465755666•6–6—6˜6­6æ6Ą6Š6ō6ż6"7#7$7&7'7)7*7,7-7/707W7X7Y7Z7e7f7g7r7s7t7w7˜0€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€8˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜ 0€€€˜0€€€˜0€€˜0€€€˜0€€€˜ 0€€€˜0€€€˜0€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ @0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0 €€€˜0€€€˜ 0 €€€˜0€€€˜ 0 €€€˜0€€€˜ 0 €€€˜0€€˜0€€˜ 0€€€˜0€€€˜ 0į €€˜0€€€˜ 0į €€˜0€€€˜ 0į €˜0€€˜ 0į €˜0€€˜ 0į €€˜0€€€˜0€€€˜ 0€€€˜0€€€˜ 0Ż€˜0€€˜ 0€˜0€€€˜ 0€€˜0€€€˜ 0€€˜0€€€˜ 0€€˜0€€€˜ 0€€˜0€€€˜ 0€€˜0€€€˜ 0€˜0€€˜ 0€€˜0€€€˜ 0€€€˜0€€€˜ 0•€˜0€€˜ 0•€€˜0€€€˜0€€€˜ 0€€€˜0€€€˜ 0 €€˜0€€€˜ 0 €€˜0€€€˜ 0×€€˜0€€€˜ 0×€€˜0€€€˜ 0×€€˜0€€€˜ 0×€˜0€€€˜0€€€˜ 0€€€˜0€€€˜ 0Ć!€€˜0€€€˜ 0Ć!€€˜0€€€˜ 0Ć!€€˜0€€€˜0€€˜ 0€€€˜0€€€˜ 0†#€˜0€€˜ 0†#€˜0€€€˜0€€˜ 0€€€˜0€€€˜ 0W%€˜0€€˜ 0W%€˜0€€˜ 0ī%€˜0€€˜ 0ī%€€˜0€€€˜ 0ī%€€˜0€€€˜ 0ī%€€˜0€€˜ 0ī%€˜0€€€˜ 0W%€˜0€€˜ 0W%€€˜0€€€˜ 0W%€€˜0€€€˜ 0W%€˜0€€˜ 0W%€€˜0€€€˜0€€€˜ 0 €€€˜0€€€˜ 0Ń,€€˜0€€€˜ 0Ń,€€˜0€€€˜ 0Ń,€€˜0€€€˜ 0Ń,€˜0€€€˜ 0Ń,€€˜0€€€˜0€€€˜ 0 €€€˜0€€€˜ 0ī0€€˜0€€€˜ 0ī0€€˜0€€€˜ 0Ź1€€˜0€€€˜ 0Ź1€€˜0€€€˜ 0Ź1€€˜0€€€˜ 0Ź1€€˜0€€€˜ 0Ź1€€˜0€€€˜ 0ī0€€˜0€€€˜ 0ī0€€˜0€€€˜0€€€˜ 0 €€€˜0€€€˜ 0—4€€˜0€€€˜ 0Ć4€€˜0€€€˜ 0Ć4€€˜0€€€˜0€€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€€˜0€€˜@0€€€Iˆ00Ŗ˜@0€€€Iˆ00Ŗ˜@0€€Iˆ00Ŗ˜@0€€Iˆ00Ŗ˜@0€€˜@0€€˜@0€€˜@0€€€˜@0€€€˜@0€€€˜@0€€€˜@0€€˜@0€€˜@0€€€Iˆ00Ŗ6f‚“µ¹ŗ»¼ÜŻĮĀĆĻŠBCŻŽNO×ŲWXäåEFķ  õ ö ‚ ƒ Ŗ « | } ß ą į   » ¼ 9:łścdŪÜŻ_`±²žŸ^_XYYZmn “•¦§45   /0Ö×67ưżž® Æ Į!Ā!Ć!ģ!ķ!Œ""*#+#„#…#†#³#“#F$U%V%W%m%n%ī%·&2'( (¢(£(ż()‚)‹*-+.+j+k+^,Ļ,Š,Ń,--ķ-ī-Ķ.Ī.°/±/ 0 0ģ0ķ0ī011É1Ź1Ł2Ś2ņ2ó2 3 3,3-3F3G3‰3Š344•4—4Ā4Ć465755666•6–6—6˜6­6æ6Ą6Š6"7#7$7W7X7Y7g7r7s7w7˜0€€p€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜ 0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜ 0€€€˜0€€€˜0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ 0€€€˜0€€€˜ @0€€€˜ 0€€˜0€€˜ 0€€˜0€€˜ 0 €€˜0€€˜ 0 €€˜0€€˜ 0 €€˜0€€˜ 0 €€˜0€€˜0€€˜ 0€€˜0€€˜ 0į €˜0€€˜ 0į €˜0€€˜ 0į €˜0€€˜ 0į €˜0€€˜ 0į €˜0€€˜0€€˜ 0€€˜0€€˜ 0Ż€˜0€€˜ 0€˜0€€˜ 0€˜0€€˜ 0€˜0€€˜ 0€˜0€€˜ 0€˜0€€˜ 0€˜0€€˜ 0€˜0€€˜ 0€˜0€€˜ 0€€˜0€€˜ 0•€˜0€€˜ 0•€˜0€€˜0€€˜ 0€€˜0€€˜ 0 €˜0€€˜ 0 €˜0€€˜ 0×€˜0€€˜ 0×€˜0€€˜ 0×€˜0€€š 0×€˜0€€˜0€€˜ 0€€˜0€€˜ 0Ļ!€˜0€€˜ 0Ļ!€˜0€€˜ 0Ļ!€˜0€€˜0€€˜ 0€€˜0€€š0€€š 0’#€˜0€€˜0€€˜ 0€€˜0€€š0€€š0€€š0€€˜ 0ł%€˜0€€˜ 0ł%€˜0€€˜ 0ł%€š 0ł%€˜0€€š0€€˜ 0`%€˜0€€˜ 0`%€˜0€€š0€€˜ 0`%€˜0€€˜0€€˜ 0 €€˜0€€˜ 0ä,€˜0€€˜ 0ä,€˜0€€˜ 0ä,€˜0€€š 0ä,€˜0€€˜ 0ä,€˜0€€˜0€€˜ 0 €€˜0€€˜ 0ž0€˜0€€š 0ž0€˜0€€˜ 0Ś1€˜0€€˜ 0Ś1€˜0€€˜ 0Ś1€˜0€€˜ 0Ś1€˜0€€˜ 0Ś1€˜0€€˜ 0ž0€˜0€€˜ 0ž0€š0€€˜ 0 €€˜0€€˜ 0©4€˜0€€˜ 0Õ4€˜0€€˜ 0Õ4€˜0€€˜0€€š0€€š0€€š0€€š0€€š0€€š0€€˜0€€š€€š@0€€š@0€€š@0€€KČ00DČ’@0€€š@0€€ 00P 6CPPPPPPPPPS•"Ļ4%?v? '*05» Ż ķįÜm!/$Į)“+0]4ķ8,;Ā<­>W?v?!#$%&()+,-./12346u?"(/16=?CJLS!’•€!t’•€!ō’•€š@š  @ń’’’€€€÷šH šš0š( š šš’šš0š( š ššB šS šæĖ’ ?š’’ÜŖUŌĢŖŻŖUĢ墎ŖUx¤ßŖUlņžąŖU$Ø¢įŖUĢŁŖāŖUd˜ćŖU¬ÄŸäŖU\ƒšåŖUœƒšęŖU܃šēŖU¬.˜čŖUģ.˜éŖU,/˜źŖUl/˜ėŖUdēžģŖU¤ēžķŖUäēžīŖU$čžļŖUL˜šŖUŒ˜ńŖUĢ˜ņŖU ˜óŖU„ˆšōŖUĈš88>ōōśżżŪ į ; ; ® ® “ 77Y&Y&_&w7      =DDł  ą ē @ @ ³ ŗ ŗ <<^&e&e&w7  9*€urn:schemas-microsoft-com:office:smarttags€State€9*€urn:schemas-microsoft-com:office:smarttags€place€=*€urn:schemas-microsoft-com:office:smarttags €PlaceType€=*€urn:schemas-microsoft-com:office:smarttags €PlaceName€ ØžĻ$7$7&7&7'7'7)7*7,7-7/707t7w7ńō$7$7&7&7'7'7)7*7,7-7/707t7w733ø¹ŪŪÜŻžĮĀĪĪĻŠ}~  S S ß ą ųłbcŪÜWW^`įå>?ll“”¦¦34  z{V!W!d!e!Į!Ā!„#…#D$E$C%K%U%V%n%ķ%µ&¶&0'1'ż(ž(‰*Š*\,],Ļ,Š,ģ/ō/õ/ö/ģ0ķ0a2b2•4–4—6"7#7$7&7'7'7)7*7,7-7/7L7V7Z7d7g7q7w7$7$7&7&7'7'7)7*7,7-7/707t7w7¬_-ģCŽ’’’’’’’’’„t .Ķ„ž’’’’’’’’’×4 ģCŽ’’’’’’’’’gV%ģCŽ’’’’’’’’’r=&²BŲŅ’’’’’’’’’ćZ¾6¤)>%’’’’’’’’’±š.±š<:ĘTG’’’’’’’’’*6ĘC2Õ~›’’’’’’’’’øE“M“+6‹’’’’’’’’’õk×U~ÅöŅ’’’’’’’’’eC[YŲ‚¢e’’’’’’’’’^€['p’’’’’’’’’b`wa2Õ~›’’’’’’’’’2!¦cjŌf’’’’’’’’’ !ŠeB{œ ’’’’’’’’’Ō^n`)č’’’’’’’’’ajx`)č’’’’’’’’’F•y²"¬M’’’’’’’’’„f„šüĘf^„f`„šüo(„ī„šüĘī^„ī`„šüo(.„v„šüĘv^„v`„šüo(..„ž „šüĘž ^„ž `„šüo(... „X„ČūĘX^„X`„Čūo( .... „ą„ČūĘą^„ą`„Čūo( ..... „Š„`śĘŠ^„Š`„`śo( ...... „X„`śĘX^„X`„`śo(....... „H„ųųĘH^„H`„ųųo(........„–„zžĘ–^„–`„zžo(.€„ „˜žĘ ^„ `„˜ž.‚„p„L’Ęp^„p`„L’.€„@ „˜žĘ@ ^„@ `„˜ž.€„„˜žĘ^„`„˜ž.‚„ą„L’Ęą^„ą`„L’.€„°„˜žĘ°^„°`„˜ž.€„€„˜žĘ€^„€`„˜ž.‚„P„L’ĘP^„P`„L’.„f„šüĘf^„f`„šüo(„ī„šüĘī^„ī`„šüo(.„v„šüĘv^„v`„šüo(..„ž „šüĘž ^„ž `„šüo(... „X„ČūĘX^„X`„Čūo( .... „ą„ČūĘą^„ą`„Čūo( ..... „Š„`śĘŠ^„Š`„`śo( ...... „X„`śĘX^„X`„`śo(....... „H„ųųĘH^„H`„ųųo(........„f„šüĘf^„f`„šüo(„ī„šüĘī^„ī`„šüo(.„v„šüĘv^„v`„šüo(..„ž „šüĘž ^„ž `„šüo(... „X„ČūĘX^„X`„Čūo( .... „ą„ČūĘą^„ą`„Čūo( ..... „Š„`śĘŠ^„Š`„`śo( ...... „X„`śĘX^„X`„`śo(....... „H„ųųĘH^„H`„ųųo(........h„x„˜žĘx^„x`„˜ž6CJo(‡hˆH.€ „ „˜žĘ ^„ `„˜ž‡hˆH.‚ „p„L’Ęp^„p`„L’‡hˆH.€ „@ „˜žĘ@ ^„@ `„˜ž‡hˆH.€ „„˜žĘ^„`„˜ž‡hˆH.‚ „ą„L’Ęą^„ą`„L’‡hˆH.€ „°„˜žĘ°^„°`„˜ž‡hˆH.€ „€„˜žĘ€^„€`„˜ž‡hˆH.‚ „P„L’ĘP^„P`„L’‡hˆH.„x„˜žĘx^„x`„˜ž6o(.„H „˜žĘH ^„H `„˜ž.‚„ „L’Ę ^„ `„L’.€„č„˜žĘč^„č`„˜ž.€„ø„˜žĘø^„ø`„˜ž.‚„ˆ„L’Ęˆ^„ˆ`„L’.€„X„˜žĘX^„X`„˜ž.€„(„˜žĘ(^„(`„˜ž.‚„ų„L’Ęų^„ų`„L’. „X„ØżĘX^„X`„Øż56o(.0 „(„ØżĘ(^„(`„Øż567o(.„p„0żĘp^„p`„0żo(..„@ „0żĘ@ ^„@ `„0żo(... „x„ČūĘx^„x`„Čūo( .... „H„ČūĘH^„H`„Čūo( ..... „€„`śĘ€^„€`„`śo( ...... „P„`śĘP^„P`„`śo(....... „ˆ„ųųĘˆ^„ˆ`„ųųo(........ „Y„·żĘč^„Y`„·żo(‡hˆH. „ „˜žĘ ^„ `„˜ž‡hˆH. „p„L’Ęp^„p`„L’‡hˆH. „@ „˜žĘ@ ^„@ `„˜ž‡hˆH. „„˜žĘ^„`„˜ž‡hˆH. „ą„L’Ęą^„ą`„L’‡hˆH. „°„˜žĘ°^„°`„˜ž‡hˆH. „€„˜žĘ€^„€`„˜ž‡hˆH. „P„L’ĘP^„P`„L’‡hˆH.„Y„·żĘč^„Y`„·ż6CJOJQJo(‡hˆH. „ „˜žĘ ^„ `„˜ž‡hˆH. „p„L’Ęp^„p`„L’‡hˆH. „@ „˜žĘ@ ^„@ `„˜ž‡hˆH. „„˜žĘ^„`„˜ž‡hˆH. „ą„L’Ęą^„ą`„L’‡hˆH. „°„˜žĘ°^„°`„˜ž‡hˆH. „€„˜žĘ€^„€`„˜ž‡hˆH. „P„L’ĘP^„P`„L’‡hˆH.„Š„0żĘŠ^„Š`„0ż5o(„ „0żĘ ^„ `„0ż5o(.„p„0żĘp^„p`„0ż5o(..„Ø „ČūĘØ ^„Ø `„Čū5o(... „x„ČūĘx^„x`„Čū5o( .... „°„`śĘ°^„°`„`ś5o( ..... „€„`śĘ€^„€`„`ś5o( ...... „ø„ųųĘø^„ø`„ųų5o(....... „ˆ„ųųĘˆ^„ˆ`„ųų5o(........„Š„0żĘŠ^„Š`„0żo(.0„ „0żĘ ^„ `„0żo(.„p„0żĘp^„p`„0żo(..„Ø „ČūĘØ ^„Ø `„Čūo(... „x„ČūĘx^„x`„Čūo( .... „°„`śĘ°^„°`„`śo( ..... „€„`śĘ€^„€`„`śo( ...... „ø„ųųĘø^„ø`„ųųo(....... „š„÷Ęš^„š`„÷o(........ „Y„·żĘč^„Y`„·żo(‡hˆH.€ „ „˜žĘ ^„ `„˜ž‡hˆH.‚ „p„L’Ęp^„p`„L’‡hˆH.€ „@ „˜žĘ@ ^„@ `„˜ž‡hˆH.€ „„˜žĘ^„`„˜ž‡hˆH.‚ „ą„L’Ęą^„ą`„L’‡hˆH.€ „°„˜žĘ°^„°`„˜ž‡hˆH.€ „€„˜žĘ€^„€`„˜ž‡hˆH.‚ „P„L’ĘP^„P`„L’‡hˆH. „Y„·żĘč^„Y`„·żo(‡hˆH.€ „ „˜žĘ ^„ `„˜ž‡hˆH.‚ „p„L’Ęp^„p`„L’‡hˆH.€ „@ „˜žĘ@ ^„@ `„˜ž‡hˆH.€ „„˜žĘ^„`„˜ž‡hˆH.‚ „ą„L’Ęą^„ą`„L’‡hˆH.€ „°„˜žĘ°^„°`„˜ž‡hˆH.€ „€„˜žĘ€^„€`„˜ž‡hˆH.‚ „P„L’ĘP^„P`„L’‡hˆH.h„Š„˜žĘŠ^„Š`„˜žOJQJ^Jo(‡hˆHoh„ „˜žĘ ^„ `„˜žOJQJ^Jo(‡hˆHoh„p„˜žĘp^„p`„˜žOJQJo(‡hˆH§šh„@ „˜žĘ@ ^„@ `„˜žOJQJo(‡hˆH·šh„„˜žĘ^„`„˜žOJQJ^Jo(‡hˆHoh„ą„˜žĘą^„ą`„˜žOJQJo(‡hˆH§šh„°„˜žĘ°^„°`„˜žOJQJo(‡hˆH·šh„€„˜žĘ€^„€`„˜žOJQJ^Jo(‡hˆHoh„P„˜žĘP^„P`„˜žOJQJo(‡hˆH§šh „ą„˜žĘą^„ą`„˜ž‡hˆH.h „° „˜žĘ° ^„° `„˜ž‡hˆH.’h „€ „L’Ę€ ^„€ `„L’‡hˆH.h „P„˜žĘP^„P`„˜ž‡hˆH.h „ „˜žĘ ^„ `„˜ž‡hˆH.’h „š„L’Ęš^„š`„L’‡hˆH.h „Ą„˜žĘĄ^„Ą`„˜ž‡hˆH.h „„˜žĘ^„`„˜ž‡hˆH.’h „`„L’Ę`^„``„L’‡hˆH.„Y„·żĘY^„Y`„·żo(.€„H „˜žĘH ^„H `„˜ž.‚„ „L’Ę ^„ `„L’.€„č„˜žĘč^„č`„˜ž.€„ø„˜žĘø^„ø`„˜ž.‚„ˆ„L’Ęˆ^„ˆ`„L’.€„X„˜žĘX^„X`„˜ž.€„(„˜žĘ(^„(`„˜ž.‚„ų„L’Ęų^„ų`„L’.„Y„·żĘY^„Y`„·żo(.„H „˜žĘH ^„H `„˜ž.„ „L’Ę ^„ `„L’.„č„˜žĘč^„č`„˜ž.„ø„˜žĘø^„ø`„˜ž.„ˆ„L’Ęˆ^„ˆ`„L’.„X„˜žĘX^„X`„˜ž.„(„˜žĘ(^„(`„˜ž.„ų„L’Ęų^„ų`„L’.h „8„˜žĘ8^„8`„˜žo(‡hˆH.h„„˜žĘ^„`„˜žOJQJ^Jo(‡hˆHoh„Ų „˜žĘŲ ^„Ų `„˜žOJQJo(‡hˆH§šh„Ø „˜žĘØ ^„Ø `„˜žOJQJo(‡hˆH·šh„x„˜žĘx^„x`„˜žOJQJ^Jo(‡hˆHoh„H„˜žĘH^„H`„˜žOJQJo(‡hˆH§šh„„˜žĘ^„`„˜žOJQJo(‡hˆH·šh„č„˜žĘč^„č`„˜žOJQJ^Jo(‡hˆHoh„ø„˜žĘø^„ø`„˜žOJQJo(‡hˆH§še.e<ćZ¾6Ō^n„t ajx^€[b`wa*6ĘCr=&øE“M !Še×4 ¬_-gV%2!¦cF•yŪeC[Yõk×U’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’ØŃ޾                 Dؖ         +īŁ        ܶśe                          RéŽH                 €å×@PB C żQ ōX  §%ŗ!—mømT]"XŃpŒl!}"ø$$ę%Ö5&X(ŗE,`L1j6*g7+;Ēn=µ=?%A(ZA*B6NBZLD3fGW\LŹ"OŖqORČNTŅ0XŹpX“,YĮ^]”P^4a cZ@fÖ l©qq„ts>1w vx•%z|9~{%~ŌC¬€{<€Ÿ„ō,†ŁŠ˜1Œ“5:Jm[“š~”Ó•?K•ƒ6–>—ČO˜5?š³ó1ƒ)”£;”ń¢½¤(³¦¤80§«±č±«°°ä/²œF²“ʰæ“7+µ»å³¦¶²Ń²ā¶„q·²Ļ9¹åuŗ›I¾õ_ĆĒ*ÄĀƲŌĘŗ<ĘrIŹVĖnĢIĪĪZCĻ ZŠ'4ŃjSŅYLÓ©ÖLlÖHŁ}6Ū ßA4ä<ēš)ē„DéDķ–pīĒ|īĪ*ņžQó“'ōcBōōSvųNū±}ū#7w7’@€xqv7 @’’Unknown’’’’’’’’’’’’G‡z €’Times New Roman5€Symbol3& ‡z €’Arial5& ‡za€’Tahoma?5 ‡: ’Courier New;€Wingdings"1ˆšŠh‰[g®[gN£ś†':ź.d:ź.d‘#š  ““477 2ƒQšßß’żHX š’?ä’’’’’’’’’’’’’’’’’’’’’'4Ń2’’~COMMENTS RELATING TO DRAFT RULES, MAINE BIRTH DEFECTS PROGRAM: RULES AND REGULATIONS RELATING TO THE REPORTING OF THE OCCURREN Paul Gauvreau don.wismerT             ž’ą…ŸņłOh«‘+'³Ł0˜ (4LXdx Œ˜ ø Ä Š Üčšųä€COMMENTS RELATING TO DRAFT RULES, MAINE BIRTH DEFECTS PROGRAM: RULES AND REGULATIONS RELATING TO THE REPORTING OF THE OCCURRENPaul Gauvreau Normal.dot don.wismer6Microsoft Office Word@Ŗær@äP TĢ@.Žy”ŠĢ@LǤ™ŠĢ:ź.ž’ÕĶ՜.“—+,ł®DÕĶ՜.“—+,ł®¬h hp|„Œ” œ¤¬“ ¼ Gäd7ę COMMENTS RELATING TO DRAFT RULES, MAINE BIRTH DEFECTS PROGRAM: RULES AND REGULATIONS RELATING TO THE REPORTING OF THE OCCURREN TitleP <D_NewReviewCycleä  !"#$%&'()*+,-./01234567ž’’’9:;<=>?ž’’’ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~ž’’’‚ƒ„…†‡ž’’’‰Š‹ŒŽž’’’ż’’’ż’’’“ž’’’ž’’’ž’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Root Entry’’’’’’’’ ĄF€Ź°­™ŠĢ•€Data ’’’’’’’’’’’’81Table’’’’@gWordDocument’’’’knSummaryInformation(’’’’’’’’’’’’€DocumentSummaryInformation8’’’’’’’’ˆCompObj’’’’’’’’’’’’q’’’’’’’’’’’’ž’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’ž’ ’’’’ ĄFMicrosoft Office Word Document MSWordDocWord.Document.8ō9²q